We’re thrilled to announce that Argá Medtech is being recognized as one of the top 10 MedTech startups in Europe in the latest edition of Medical Tech Outlook.
Over 33 million people worldwide suffer from Atrial Fibrillation (AF). The current procedures have a long-term succession between 50 and 70%, depending on the patient population.
Argá is developing a safer, faster, and more efficient technology to create long-lasting outcomes. The Coherent Sine burst Electroporation (CSE) is a next-generation, non- thermal cardiac Pulsed Field Ablation system that offers increased flexibility when used with its proprietary catheter.
